Back to AQST
D. E. Shaw & Co., Inc. AQST Position History
Aquestive Therapeutics, Inc. • Healthcare
Quarters held
16
Latest value
$157K
Q2 2026
Peak value
$5.7M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $99K |
| Q2 2022 | $7K |
| Q1 2024 | $406K |
| Q2 2024 | $26K |
| Q3 2024 | $155K |
| Q4 2024 | $144K |
| Q4 2024 | $307K |
| Q1 2025 | $357K |
| Q1 2025 | $162K |
| Q2 2025 | $72K |
| Q2 2025 | $142K |
| Q3 2025 | $143K |
| Q4 2025 | $425K |
| Q4 2025 | $5.7M |
| Q1 2026 | $75K |
| Q2 2026 | $157K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $157K | 37.6K | — | — |
| Q1 2026 | $75K | 18.1K | — | — |
| Q4 2025 | $5.7M | 875.3K | — | — |
| Q4 2025 | $425K | 65.9K | — | — |
| Q3 2025 | $143K | 25.5K | — | — |
| Q2 2025 | $142K | 42.9K | — | — |
| Q2 2025 | $72K | 21.8K | — | — |
| Q1 2025 | $162K | 55.8K | — | — |
| Q1 2025 | $357K | 123.2K | — | — |
| Q4 2024 | $307K | 86.1K | — | — |
| Q4 2024 | $144K | 40.4K | — | — |
| Q3 2024 | $155K | 31.0K | — | — |
| Q2 2024 | $26K | 10.2K | — | — |
| Q1 2024 | $406K | 95.2K | — | — |
| Q2 2022 | $7K | 10.2K | — | — |
| Q2 2022 | $99K | 154.4K | — | — |